Eton Pharmaceuticals, Inc. · NASDAQ:ETON

BlackRock, Inc. reported a 6.90% stake in Eton Pharmaceuticals, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 28, 2026

BlackRock, Inc. reported a 6.90% stake in Eton Pharmaceuticals, Inc., 1,882,410 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G/A).

Stake
6.90%
Shares
1,882,410
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.6.90%1,882,410

Source

View original at SEC

Related